Search | Page 14 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

    ... recover faster following a stem cell transplant . Blood stem cells are very young blood cells that grow in the body to ... (MDS): RA/RCMD with high risk cytogenetic features or transfusion dependence, RAEB-1 and RAEB-2 Chronic myelomonocytic leukemia: ...

    Clinical Trial last updated 04/29/2016 - 1:11pm.

  2. Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

    ... are partial, with only a few patients achieving normal blood counts. Furthermore, analysis of our own extensive clinical data suggests ... to a single course of ATG (non-robust responders), even when transfusion-independence is achieved, predicts a worse prognosis than when ...

    Clinical Trial last updated 04/25/2016 - 2:47pm.

  3. Iron Overload and MDS

    ... Anemia , having low number of red blood cells (RBC), affects 80% of patients with MDS, with a substantial ... a short period of time. The amount of iron in a single RBC transfusion is the same as 1,280 cups of cooked spinach. The buildup of iron in ...

    Research Review last updated 05/02/2016 - 9:18am.

  4. Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    ... stem cell transplant may be able to replace blood-forming cells that were destroyed by chemotherapy and radiation ... (RA) or all IPSS categories if severe pancytopenia , transfusion requirements not responsive to therapy, or high risk ...

    Clinical Trial last updated 05/02/2016 - 2:20pm.

  5. Allo HSCT Using RIC for Hematological Diseases

    ... < 0.8, Anemia or thrombocytopenia requiring transfusion; Poor or very poor risk cytogenetics based on IPSS or R-IPSS ... to a fetus. Females of childbearing potential must have a blood test or urine study within 14 days prior to registration to rule out ...

    Clinical Trial last updated 05/02/2016 - 9:29am.

  6. Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    ... of a specific kind of transplant. In this transplant, blood from two donors will be used. Each donor will share one half of your HLA ... (MDS): RA/RCMD with high risk cytogenetic features or transfusion dependence, RAEB-1 and RAEB-2 and Acute myelogenous leukemia ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.

  7. MDS Patient Becomes a Role Model

    ... and things became very serious. Because the MDS affected our blood counts, and in turn our immune systems, we both caught rare infections ... centers, and nursing homes. She has to get a blood transfusion about once a week now. Because everything happened so suddenly, ...

    Patient Chronicle last updated 04/22/2016 - 5:19pm.

  8. Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

    ... compared to filgrastim (G-CSF) mobilized peripheral blood stem cell (PBSC) transplants, BM allografts have lower CD34+ progenitor ... thrombosis , and/or cytopenia , and/or transfusion dependence and/or recurrent and debilitating hemolytic crisis ...

    Clinical Trial last updated 04/28/2016 - 2:40pm.

  9. Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    ... after transplant. Eligibility: - Adults 18 70 with blood or bone marrow cancer with no HLA-matched sibling, but with a ... risk: Hemoglobin < 10 g/dl, or > 10 g/dl with transfusion dependence. WBC < 4,000 or > 30,000/mm3 or requires ...

    Clinical Trial last updated 04/29/2016 - 1:00pm.

  10. UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

    ... according to current University of Minnesota umbilical cord blood graft selection algorithm. ... Severe Cytopenias: ANC < 0.8, PRBC or platelets requiring transfusion; Higher risk cytogenetics based on IPSS or R-IPSS definitions; ...

    Clinical Trial last updated 04/29/2016 - 10:06am.